Invention Grant
- Patent Title: Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
-
Application No.: US16206166Application Date: 2018-11-30
-
Publication No.: US10316018B2Publication Date: 2019-06-11
- Inventor: Katherine Lin Lee , Christophe Philippe Allais , Christoph Martin Dehnhardt , Lori Krim Gavrin , Seungil Han , David Hepworth , Arthur Lee , Frank Eldridge Lovering , John Paul Mathias , Dafydd Rhys Owen , Nikolaos Papaioannou , Eddine Saiah , Joseph Walter Strohbach , John David Trzupek , Stephen Wayne Wright , Christoph Wolfgang Zapf
- Applicant: PFIZER INC.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent James T. Wasicak
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; A61K31/4709 ; A61K31/4725 ; A61K31/4745 ; A61K31/4015 ; A61K45/06 ; C07D401/12 ; C07D413/04 ; C07D207/273 ; C07D491/18 ; C07D471/04 ; C07D413/14 ; C07D401/14
Abstract:
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20190092750A1 BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS Public/Granted day:2019-03-28
Information query
IPC分类:
